Wednesday, January 11, 2023 6:20:41 PM
Ok obtuse. I do respect your perspective even if I choose to not agree.
It doesn’t change my perspective about what MF needs to do to unlock the pps
If he won’t partner or can’t get funding or chooses to tango with fda the pps will remain depressed. I’m not holding a heavy bag but and I want to make money like everyone else
Glta
It doesn’t change my perspective about what MF needs to do to unlock the pps
If he won’t partner or can’t get funding or chooses to tango with fda the pps will remain depressed. I’m not holding a heavy bag but and I want to make money like everyone else
Glta
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
